Sulfamethoxazole
Sponsors
Hansa Biopharma AB, The University Of Queensland, Lederle Laboratories, U.S. Bioscience, Jacobus Pharmaceutical
Conditions
Anti-GBM antibody disease (Goodpasture disease)BronchitisDiabetes Mellitus, Insulin-DependentHIV InfectionsHypotonia Cystinuria SyndromeIsolated PREPL DeficiencyMycobacterium abscessus pulmonary diseasePneumonia, Pneumocystis Carinii
Phase 1
Phase 2
Islet Transplantation for Type 1 Diabetes
CompletedNCT00014911
Start: 2001-04-30End: 2010-08-31Updated: 2017-03-15
Sulfamethoxazole for the Treatment of Primary PREPL Deficiency
NCT02640443
Start: 2015-10-31End: 2016-10-31Target: 15Updated: 2015-12-29
Finding the Optimal Regimen for Mycobacterium abscessus Treatment
RecruitingCTIS2023-506575-99-00
Start: 2023-01-02Target: 20Updated: 2025-10-13
Phase 3
Unknown Phase
A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
CompletedNCT00002283
Updated: 2005-06-24
A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
CompletedNCT00002002
Updated: 2005-06-24
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
CompletedNCT02879981
Start: 2016-11-10End: 2017-08-28Updated: 2019-12-13
A Non-Interventional Safety Study of Balsamic Bactrim
CompletedNCT02902640
Start: 2016-11-15End: 2017-07-31Updated: 2017-11-07